Evidence map›Paper›PMID 36400984›Full record

Trial reportIntensive care medicine2022

Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial.

Gonzalo Hernández, Irene Paredes, Francisco Moran, Marcos Buj, Laura Colinas, María Luisa Rodríguez, Alfonso Velasco, Patricia Rodríguez, María José Pérez-Pedrero, Fernando Suarez-Sipmann and 4 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06301035 (Comparison of Asymmetric High-flow Nasal Cannula), which is not on this map. Cited by 56 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 5 pooled it
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06301035 nacompletednot on this mapstarted 2024, after this paper: background citation

Comparison of Asymmetric High-flow Nasal Cannula (HFNC) and Standard HFNC in Post Extubation High-risk Group: A Prospective, Single-center, Open-labeled, Randomized Controlled Pilot Study

TypeinterventionalSponsorSamsung Medical CenterRan2024 to 2025Enrolled30ConditionsAcute Respiratory FailureArmsAsymmetric High flow nasal cannula, Standard(symmetric) High flow nasal cannula
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 5 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Gonzalo HernándezVirgen de la Salud Hospital, Toledo, Spain. ghernandezm@telefonica.net.ORCID http://orcid.org/0000-0003-2261-4487
Irene ParedesVirgen de la Salud Hospital, Toledo, Spain.
Francisco MoranVirgen de la Salud Hospital, Toledo, Spain.
Marcos BujVirgen de la Salud Hospital, Toledo, Spain.
Laura ColinasVirgen de la Salud Hospital, Toledo, Spain.
María Luisa RodríguezVirgen de la Salud Hospital, Toledo, Spain.
Alfonso VelascoVirgen de la Salud Hospital, Toledo, Spain.
Patricia RodríguezVirgen de la Salud Hospital, Toledo, Spain.
María José Pérez-PedreroVirgen de la Salud Hospital, Toledo, Spain.
Fernando Suarez-SipmannLa Princesa University Hospital, Madrid, Spain.
Alfonso CanabalLa Princesa University Hospital, Madrid, Spain.
Rafael CuenaResearch Unit, Medical Council, Toledo, Spain.
Lluis BlanchParc Taulí Hospital Universitari, Institut de Investigació i Innovació Parc Taulí (I3PT), Sabadell, Spain.
Oriol RocaParc Taulí Hospital Universitari, Institut de Investigació i Innovació Parc Taulí (I3PT), Sabadell, Spain.
Hospital Virgen de la Salud · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital Universitario de La Princesa · ESUniversidad Francisco de Vitoria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHigh-flow nasal cannula (HFNC) oxygen therapy was noninferior to noninvasive ventilation (NIV) for preventing reintubation in a heterogeneous population at high-risk for extubation failure. However, outcomes might differ in certain subgroups of patients. Thus, we aimed to determine whether NIV with active humidification is superior to HFNC in preventing reintubation in patients with ≥ 4 risk factors (very high risk for extubation failure).

methodsRandomized controlled trial in two intensive care units in Spain (June 2020‒June 2021). Patients ready for planned extubation with ≥ 4 of the following risk factors for reintubation were included: age > 65 years, Acute Physiology and Chronic Health Evaluation II score > 12 on extubation day, body mass index > 30, inadequate secretions management, difficult or prolonged weaning, ≥ 2 comorbidities, acute heart failure indicating mechanical ventilation, moderate-to-severe chronic obstructive pulmonary disease, airway patency problems, prolonged mechanical ventilation, or hypercapnia on finishing the spontaneous breathing trial. Patients were randomized to undergo NIV with active humidification or HFNC for 48 h after extubation. The primary outcome was reintubation rate within 7 days after extubation. Secondary outcomes included postextubation respiratory failure, respiratory infection, sepsis, multiorgan failure, length of stay, mortality, adverse events, and time to reintubation.

resultsOf 182 patients (mean age, 60 [standard deviation (SD), 15] years; 117 [64%] men), 92 received NIV and 90 HFNC. Reintubation was required in 21 (23.3%) patients receiving NIV vs 35 (38.8%) of those receiving HFNC (difference -15.5%; 95% confidence interval (CI) -28.3 to -1%). Hospital length of stay was lower in those patients treated with NIV (20 [12‒36.7] days vs 26.5 [15‒45] days, difference 6.5 [95%CI 0.5-21.1]). No additional differences in the other secondary outcomes were observed.

conclusionsAmong adult critically ill patients at very high-risk for extubation failure, NIV with active humidification was superior to HFNC for preventing reintubation.

Indexed as

Airway ExtubationNoninvasive VentilationAdultAgedCannulaFemaleHumansIntubation, IntratrachealMaleMiddle AgedRespiration, ArtificialActive humidificationHigh-flow nasal cannulaNoninvasive ventilationOutcomeReintubationWeaning

Identifiers

PMID36400984
PMCPMC9676812
OpenAlexW4309667273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.